Education

IgNS  provides members with educational programs on a wide variety of topics. Advance your expertise, deepen your knowledge, and standardize your practice! Take advantage of our educational programs on disease states, Ig products and individualization of therapy, treatment protocols, patient management, advocacy, legislative/regulatory updates, and more.

Browse Courses and Activities

NEW! The Intersection of Immune Deficiency and Autoimmunity

The connection between immune deficiency and autoimmunity is well recognized.  This tangled web presents a wide variety of clinical presentations and outcomes.  Advances in understanding of the molecular and cellular biology of these diseases have led to a improvements in management and treatment options for patients.

CE Credits: 1
Accreditation: 
ANCC, ACPE

NEW! How to Support Patients Who are Isolated or Lonely

During this session learn to differentiate between social isolation and loneliness and define social well-being and to identify the risk factors and symptoms of loneliness and describe its impact on physical health, mental health, longevity, and mortality.

CE Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

NEW! The Immunology of COVID-19

Get a deeper understanding of the impact of SARS-CoV-2 on our immune system, the stages of the disease it causes, available treatments and the potential timeline of their efficacy, as well as new therapies on the horizon.

CE Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

NEW! BEE Needle Fear Friendly

This program presents options to assess and reduce needle fear, pain, and vasovagal syncope with Ig therapy, including topical anesthetics, cognitive interventions, and Buzzy best practices.

CE Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

NEW! The Intersection of Immune Deficiency and Autoimmunity

The connection between immune deficiency and autoimmunity is well recognized.  This tangled web presents a wide variety of clinical presentations and outcomes.  Advances in understanding of the molecular and cellular biology of these diseases have led to a improvements in management and treatment options for patients.

CE Credits: 1
Accreditation: 
ANCC, ACPE

NEW! IVIg in the Treatment of Autoimmune Blistering Diseases

Intravenous immunoglobulin (IVIg) has been shown to be effective in the treatment for autoimmune blistering diseases like pemphigus vulgaris and bullous pemphigoid. While the precise mechanism of action is unknown, high-dose IVIg can be effective in achieving and maintaining remission in these disorders. This session describes the different types of autoimmune blistering diseases, and the available treatment modalities for patients.

CE Credits: 1
Accreditation: 
ANCC, ACPE

NEW! Solid Organ Transplantation

Ig therapy plays an important immunomodulatory role in organ transplantation. Evidence of Ig use for the desensitization of patients undergoing transplantation demonstrates improvement in clinical outcomes and transplantation success rates. As the use of Ig therapy expands in this patient population, it is important to understand the differences in Ig product formulations, and appropriate ways to select the right product for this clinical use.

CE Credits: 1
Accreditation: 
ANCC, ACPE

NEW! Building a Culture of Safety: No Heroes Allowed

This program addresses the history and current state of preventable medical harm in the U.S. and the impact teamwork deficiencies on patient outcomes. The audience will be drawn into a conversation on the impact of our hierarchical structure on patient care. This presentation includes real-life case studies addressing common challenges and communication barriers, and invites the participant to identify steps to hold personal accountability for contributing to a culture of safety.

CE Credits: 1
Accreditation: 
ANCC, ACPE

Bronchiectasis in Primary Immunodeficiency

Bronchiectasis is a complication observed with patients diagnosed chronic variable immunodeficiency.  This session will describe pathophysiology, presentation, and diagnostic markers of bronchiectasis.  This session will discuss management approaches, and disease-specific tools for evaluation in these patients.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Compliance and Risk Management

This session will focus on mitigation of risks in healthcare organizations through establishing specific compliance policies.  This session will describe risk reduction and practice improvement strategies, and various practice resources available.  Therapy adherence and appropriate adverse event reporting will also be discussed.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

CVID: Overview of Genetic Causes and Diagnostic Testing

The session will describe the known genetic causes of CVID, focusing on recent patient and family case studies. The speakers will overview the clinical presentation of patients with common variable immunodeficiency (CVID), as well as other common causes of low Ig levels. Laboratory tests essential for the diagnosis of CVID will be reviewed, and IVIG and SCIG therapy in CVID will be discussed.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Enhancing Patient Quality of Life: Roles and Responsibilities in a Healthcare Professional Team

This session will overview collaborative pathways for multi-disciplinary teams, and describe the value of this approach in healthcare organizations providing Ig therapy and other complex therapeutic interventions.  Effective communication, coordination of services, and optimizing patient care will be discussed.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Examining the Application of Immunoglobulin in Multiple Disease States: A Review of Evidence

The administration of immunoglobulin (Ig) has become common practice in the treatment of patients with immunodeficiencies, and, more recently, in other disorders, including inflammatory diseases and autoimmune neuropathies. Patients with these disorders experience significant morbidity and mortality, and the often life-altering consequences of these diseases can also have substantial direct and indirect costs accounting for billions of dollars impacting the US economy. With the continual research into the genetic basis of disease, more data will be forthcoming on the evolving use of Ig in patients with genetic abnormalities. Healthcare professionals require proper training and foundational knowledge on best practices for the use of Ig agents to provide patients with clinically appropriate and cost-effective individualized options for therapy that will improve treatment outcomes and overall quality of life.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Exercising with Peripheral Neuropathy

This session will focus on discussing the underlying causes of various neuropathies and understanding the goals of physical therapy, including improvement in function, flexibility and strength, balance, and reducing pain.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Ig Manufacturing Process: Past, Present, and Future

This presentation will provide an overview of the history of Ig products with a focus on the manufacturing processes. The various manufacturing processes employed today will be discussed in detail and will include methods used for isolation, purification, viral removal/inactivation, and formulation. Utilizing the information presented, instruction as to how to review a product Package Insert will be discussed as well as how to compare products. Finally, newer methods under study and recombinant Ig products will be reviewed and what their future role may be.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Ig Product Selection Strategies

This presentation will provide an overview of the history of Ig products and explain the differences between products. Utilizing this information, guidelines will be presented for choosing the most appropriate Ig product for each patient, taking into account product differences and patient risk factors. Finally, case studies will be discussed to demonstrate how to implement the information presented.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Ig Related Aseptic Meningitis

This session will discuss aseptic meningitis, a serious adverse reaction observed with IVIG administration.  Risk factors, clinical presentation, management options, and sequelae will be discussed.  Options for treating patients with history of  aseptic meningitis will be provided.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Ig Therapy for Antibody Mediated Diseases

This session will overview the role of antibodies in the pathogenesis of various disorders.  The various mechanisms of action of Ig therapy in antibody-mediated diseases, pharmacokinetics, and other factors that characterize clinical response will be discussed, as will the individualization of therapy to optimize response.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Ig Through the Ages

This discussion will focus on understanding the issues with treatment and management of pediatric, adolescent, and geriatric patients with IVIG and SCIG therapy. Further, the faculty will discuss important approaches to dosing and management of special populations, including pregnancy, obesity, renal dysfunction, thromboembolic risk, infection, and more.

CE/CME Credits: 1.5
Accreditation: 
ANCC, ACPE, ACCME

Ig Treatment Planning

Ig therapy treatment planning requires a systematic, standardized approach.  This session will focus on identifying the most important parameters of treatment planning including risk factor assessment, administration management, site of care consideration, patient education requirements, and cultural perspectives.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Legislative and Reimbursement Updates

Understanding the current issues that impact Ig therapy reimbursement is critical to ensuring patients’ access to therapy.  Healthcare professional should participate in advocacy and understand the legistlative processes that impacts decision making in Congress. This session will provide an overview of these topics, and help healthcare professionals build awareness and improve advocacy for their patients.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Needle Phobia, Pain, Anxiety, and Therapy Avoidance

Needle phobia has had an overwhelming rise in prevalence in the past two decades. Dr. Baxter’s session discusses evidence-based causes and consequences of needle fear, and dives into multiple approaches to alleviate both needle pain and fear. In addition, the factors contributing to vasovagal symptoms with needle procedures will be discussed, as well as the best current data on ways to identify and address the needle anxious patient to facilitate faster procedures and greater adherence.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Pharmacogenomics: Evidence and Thinking

This session will review sources of pharmacogenomic information, including the core data in the Clinical Pharmacogenetic Implementation Consortium (CPIC) guidelines.  The learner will be able to recognize the link between pharmacogenomics and drug dose selection; relate genetics to drug exposure in the context of various patient populations; and identify the general “direction” of drug dosing when guidelines do not exist.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Practical Applications in the Care of the Neurology Patient

Dr. Muppidi, Stanford University, will review the most common neuromuscular disorders treated with Ig therapy. This webinar will incorporate discussion of clinical and disease-specific outcome assessments into the infusion care setting. Dr. Muppidi will review appropriate monitoring in chronic Ig administration and other critical issues faced by clinicians in this field.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Rheumatologic Disorders and Ig Therapy

This session will review the benefits from Ig, address treatment options and methods used to measure the efficacy in rheumatologic disorders.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Psychosocial Issues in Chronic Illness

Living with chronic disease presents a tremendous psychosocial challenge to patients, families, friends, and caregivers. Psychosocial distress and functional impairments are often long-lasting and can worsen the course of illness, quality of life, and may feel harder to address than the disease itself. In this session, participants will explore the complex journey of chronic disease from a person- and relationship-centered perspective, and will come away with a deeper knowledge of psychosocial treatment options.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

The Role of Subcutaneous Immunoglobulin in Myasthenias Gravis and CIDP

Dr. Dimachkie is the leading clinician and researcher in the neuromuscular disorders field. This plenary session will review the role of Ig therapy in neuromuscular disorders, the routes of administration and appropriate dosing protocols. The audience will understand the rationale for subcutaneous Ig therapy trials in neuromuscular disorders, discuss clinical trials, and the efficacy and safety of SCIg in neuromuscular disorders.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

The Scarlet Letter: Anti-A and Anti-IgA

Dr. Draper’s session will focus on understanding the IVIG-mediated hemolysis due to ABO antibodies, and anaphylaxis due to anti-IgA.  Dr. Draper will explore the pathogenesis and risk factors of hemolysis and anaphylaxis due to IVIG administration as well as ways to prevent or mitigate these adverse reactions.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Therapeutic Fc-Fusion Proteins for Benign Hematologic Disorders

This session will address the treatment approaches using Fc-fusion proteins in hematologic disorders such as Immune Thrombocytopenic Purpura (ITP), autoimmune hemolytic anemia, and hemophilia.  Mechanism of action, goals of therapy, clinical efficacy, appropriate use, and safety of these agents will discussed.

CE/CME Credits: 1
Accreditation: 
ANCC, ACPE, ACCME

Through the Rough Waters of Supply Interruptions

This program addresses the recent shortages of immunoglobulin (Ig) products are impacting the access to care of patients across the US and worldwide. It is likely that your organization and your patients are affected by the limited availability of a specific product. What are some of the factors that contribute to limited product availability? How can patients navigate the bumpy roads of product shortages? Let’s dive into these critical issues together!

CE Credits: 1
Accreditation: 
ANCC, ACPE

Stay In The Know

Join 45,000+ subscribers and receive important announcements and updates

Subscribe to our mailing list

* indicates required

Contact Us

21550 Oxnard St. Suite 980 Woodland Hills, CA 91367

1 (888) 855-4443

© IgNS Copyright 2020 - All Rights Reserved

© IgNS Copyright 2020 - All Rights Reserved